B

Biolight Life Sciences Ltd
TASE:BOLT

Watchlist Manager
Biolight Life Sciences Ltd
TASE:BOLT
Watchlist
Price: 625 ILS 1.41% Market Closed
Market Cap: 27.4m ILS
Have any thoughts about
Biolight Life Sciences Ltd?
Write Note
BOLT
/
Cash Flow Statement
/
Net Change in Cash

Biolight Life Sciences Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biolight Life Sciences Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
B
Biolight Life Sciences Ltd
TASE:BOLT
Net Change in Cash
-₪7.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
3%
Compugen Ltd
NASDAQ:CGEN
Net Change in Cash
-$5.5m
CAGR 3-Years
N/A
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Q
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Net Change in Cash
-$1.9m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Biolight Life Sciences Ltd
Glance View

Market Cap
27.4m ILS
Industry
Life Sciences Tools & Services

BioLight Life Sciences Ltd. engages in the management, research and development, investments or sale of solutions, the purpose of which is to address a real need that exists in the field of eye diseases. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.

BOLT Intrinsic Value
27.24 ILS
Overvaluation 96%
Intrinsic Value
Price
B
What is Intrinsic Value?

See Also

What is Biolight Life Sciences Ltd's Net Change in Cash?
Net Change in Cash
-7.2m ILS

Based on the financial report for Jun 30, 2024, Biolight Life Sciences Ltd's Net Change in Cash amounts to -7.2m ILS.

What is Biolight Life Sciences Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
3%

Back to Top
ALPHA SPREAD
Follow us
Join more than 202,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.